A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article published on September 28, 2011 |
| Author/s |
author: T. R. Jeffry Evans Jan H M Schellens Mark R Middleton |
| Publication date | September 28, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://link.springer.com/content/pdf/10.1007/s00280-011-1732-7.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |